BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jul 05, 2010
 |  BC Week In Review  |  Company News  |  Deals

Alnara, Eli Lilly deal

Lilly will acquire Alnara for an undisclosed amount. Alnara's lead compound is liprotamase, a non-porcine pancreatic enzyme replacement therapy under review by...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >